Oncological monitoring after transanal total mesorectal excision for rectal neoplasia
Tech Coloproctol
.
2023 Dec;27(12):1411-1412.
doi: 10.1007/s10151-023-02866-3.
Epub 2023 Oct 9.
Authors
M Gachabayov
1
,
R Bergamaschi
1
,
H Wasmuth
2
,
A Faerden
3
,
M Javadov
4
,
F Cianchi
5
,
M Barnajian
6
,
D E Popa
7
,
H Lee
8
Affiliations
1
Section of Colorectal Surgery, Westchester Medical Center, New York Medical College, Valhalla, NY, USA.
2
Department of Gastrointestinal Surgery, St Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
3
Department of Digestive Surgery, Akershus University Hospital, Akershus, Norway.
4
Department of Surgery, Yeditepe University Hospital, Istanbul, Turkey.
5
Department of Surgery and Translational Medicine, Careggi Hospital, University of Florence, Florence, Italy.
6
Division of Colorectal Surgery, Cedar Sinai Medical Center, Los Angeles, CA, USA.
7
Department of Surgery, Linköping University Hospital, Linköping, Sweden.
8
Division of Colon and Rectal Surgery, Harbor-UCLA Medical Center, Torrance, CA, USA. HLeea16bc@dhs.lacounty.gov.
PMID:
37812263
PMCID:
PMC10638161
DOI:
10.1007/s10151-023-02866-3
No abstract available